Antagonist

Results: 956



#Item
4512. MECHANISM(S) OF ACTION* - Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds - Part II

2. MECHANISM(S) OF ACTION* - Exposure and Human Health Reassessment of 2,3,7,8-Tetrachlorodibenzo-p-Dioxin (TCDD) and Related Compounds - Part II

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2004-10-15 11:36:18
452NCI Conference: Low Dose Opioid Blockers, Endorphins and Metenkephalins “Promising Compounds for Unmet Medical Needs” Executive Plaza North Bethesda, MD[removed]Attendees

NCI Conference: Low Dose Opioid Blockers, Endorphins and Metenkephalins “Promising Compounds for Unmet Medical Needs” Executive Plaza North Bethesda, MD[removed]Attendees

Add to Reading List

Source URL: www.lowdosenaltrexone.org

Language: English - Date: 2007-07-07 12:12:57
453ENCLOSURE B  Ondansetron Injection USP Rx Only DESCRIPTION The active ingredient in Ondansetron Injection USP is ondansetron hydrochloride @Xl), the

ENCLOSURE B Ondansetron Injection USP Rx Only DESCRIPTION The active ingredient in Ondansetron Injection USP is ondansetron hydrochloride @Xl), the

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2004-12-27 14:08:31
454© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology  A N A LY S I S Relating protein pharmacology by ligand chemistry

© 2007 Nature Publishing Group http://www.nature.com/naturebiotechnology A N A LY S I S Relating protein pharmacology by ligand chemistry

Add to Reading List

Source URL: shoichetlab.compbio.ucsf.edu

Language: English - Date: 2013-10-15 11:56:41
4551811 Bethlehem  Pike 2303 North

1811 Bethlehem Pike 2303 North

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 2001-02-08 11:00:22
456John Teerlink: Renaissance man and leader in heart failure research

John Teerlink: Renaissance man and leader in heart failure research

Add to Reading List

Source URL: download.thelancet.com

Language: English
457HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ® BUTRANS safely and effectively. See full prescribing information for BUTRANS. 6B

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ® BUTRANS safely and effectively. See full prescribing information for BUTRANS. 6B

Add to Reading List

Source URL: www.purduepharma.com

Language: English - Date: 2014-04-16 12:28:34
458PII: S0197[removed]

PII: S0197[removed]

Add to Reading List

Source URL: www.opto.umontreal.ca

Language: English - Date: 2008-09-29 09:58:04
459Role of Naloxone in Opioid Overdose Fatality Prevention Post Meeting Summary Naloxone is an opioid receptor antagonist that is approved for use by injection only for the reversal of opioid overdose and for adjunct use in

Role of Naloxone in Opioid Overdose Fatality Prevention Post Meeting Summary Naloxone is an opioid receptor antagonist that is approved for use by injection only for the reversal of opioid overdose and for adjunct use in

Add to Reading List

Source URL: www.fda.gov

Language: English
460Microsoft Word - EPA Dispersant In Vitro Report 30june2010 FINALx.docx

Microsoft Word - EPA Dispersant In Vitro Report 30june2010 FINALx.docx

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2010-09-02 10:17:21